Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Oncothyreon Announces Data for ONT-380 in HER2-Positive Breast Cancer Patients With and Without Brain Metastases at the San Antonio Breast Cancer Symposium
December 08, 2015 16:05 ET
|
Cascadian Therapeutics, Inc.
SEATTLE, Dec. 08, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY), a clinical-stage biopharmaceutical company dedicated to the development of therapeutic products that can improve the...
Oncothyreon Announces Webcast to Review Updated Clinical Data on ONT-380 in HER2-Positive Breast Cancer Patients
December 02, 2015 08:00 ET
|
Cascadian Therapeutics, Inc.
SEATTLE, Dec. 02, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY), a clinical-stage biopharmaceutical company dedicated to the development of therapeutic products that can improve the...
Provista Diagnostics to Present New Clinical Data at the 2015 American Society of Clinical Oncology Breast Cancer Symposium
September 23, 2015 14:00 ET
|
Provista Diagnostics, Inc.
NEW YORK, NY, Sept. 23, 2015 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a privately-held molecular diagnostics company focused on developing and commercializing a new generation of proprietary...
OncoMed Presents Biomarker-Focused Clinical Data From Phase 1a Trial of Anti-Notch1 (OMP-52M51) in Oral Plenary Session at the 26th EORTC-NCI-AACR Symposium
November 19, 2014 07:50 ET
|
OncoMed Pharmaceuticals, Inc.
BARCELONA, Spain and REDWOOD CITY, Calif., Nov. 19, 2014 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage company developing novel therapeutics that target cancer stem...
Cardiopulmonary Corp. to Demonstrate Bernoulli(R) Enterprise at the HIMSS Interoperability Showcase February 23-27, 2014
February 21, 2014 07:00 ET
|
Cardiopulmonary Corp.
MILFORD, Conn., Feb. 21, 2014 (GLOBE NEWSWIRE) -- Cardiopulmonary Corp. (CPC) today announced that its Bernoulli® Enterprise platform meets the integration testing standards of the Integrating...
Sucampo to Present Data on AMITIZA(R) (lubiprostone) in Chronic Idiopathic Constipation at Annual Meeting of the Swiss Society of Gastroenterology
September 12, 2013 19:00 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Sept. 12, 2013 (GLOBE NEWSWIRE) -- Sucampo AG ("SAG"), a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) ("Sucampo"), announced today that it will present four...
Informatica Delivers Healthcare's First Accredited Integration Adapter For dbMotion(tm)
August 15, 2012 17:17 ET
|
Informatica
REDWOOD CITY, Calif., Aug. 15, 2012 (GLOBE NEWSWIRE) -- Informatica Corporation (Nasdaq:INFA), the world's number one
independent provider of data
integration software, today introduced the...
75 Percent of Drug Companies Formally Manage Investigator-Initiated Trials
March 03, 2010 09:17 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - March 3, 2010) - Investigator-initiated trials (IITs) provide companies with clinical data to expand scientific understanding of their drugs and reap a...